Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in Myeloproliferative Neoplasms (EpiC)
Clinical trial NCT06022328 · RECRUITING
Trial details
- NCT number
- NCT06022328
- Sponsor
- University Hospital, Bordeaux
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-15
- Primary completion
- 2025-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.